On Oct 31, major Wall Street analysts update their ratings for $Mondelez International (MDLZ.US)$, with price targets ranging from $76 to $85.
BofA Securities analyst Peter Galbo maintains with a buy rating.
Citi analyst Thomas Palmer maintains with a buy rating, and adjusts the target price from $80 to $78.
Barclays analyst Andrew Lazar maintains with a buy rating, and maintains the target price at $76.
Wells Fargo analyst Christopher Carey maintains with a buy rating, and maintains the target price at $78.
Evercore analyst David Palmer maintains with a buy rating, and adjusts the target price from $79 to $85.
Furthermore, according to the comprehensive report, the opinions of $Mondelez International (MDLZ.US)$'s main analysts recently are as follows:
Following Mondelez's Q3 report, the company's reaffirmation of its full-year forecast suggests a Q4 performance that may not meet previous expectations. Additionally, the firm has indicated that its 2025 earnings could potentially see a decrease compared to the prior year. Adjustments in estimates have been made to account for the impact of cocoa price inflation, yet there remains a possibility of more positive earnings potential in the upcoming year.
Following Mondelez's Q3 results, management continues to project organic growth at the upper end of the 3%-5% range for 2024.
The assessment notes that management acknowledges the challenge in increasing earnings per share (EPS) by 2025, in addition to an expected negative impact on EPS from other factors. Nevertheless, management does not anticipate a significant downturn, merely a difficulty in achieving growth. Given the strength of organic sales and a reasonable valuation based on earnings, the company is expected to attract attention from investors.
Here are the latest investment ratings and price targets for $Mondelez International (MDLZ.US)$ from 8 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美東時間10月31日，多家華爾街大行更新了$億滋 (MDLZ.US)$的評級，目標價介於76美元至85美元。
美銀證券分析師Peter Galbo維持買入評級。
花旗分析師Thomas Palmer維持買入評級，並將目標價從80美元下調至78美元。
巴克萊銀行分析師Andrew Lazar維持買入評級，維持目標價76美元。
富國集團分析師Christopher Carey維持買入評級，維持目標價78美元。
Evercore分析師David Palmer維持買入評級，並將目標價從79美元上調至85美元。
此外，綜合報道，$億滋 (MDLZ.US)$近期主要分析師觀點如下：
在蒙德利茲(Q3)的報告發布後，公司對全年業績預測的再次確認表明可能無法達到先前預期的Q4表現。此外，公司表示，2025年的收益可能會較去年有所減少。已針對可可價格通脹的影響進行了估算調整，但仍存在着未來一年中更爲積極的收益潛力。
在蒙德利茲(Q3)的結果公佈後，管理層繼續預計2024年有機增長將位於3%-5%區間的較高端。
評估指出，管理層承認到2025年提高每股收益(EPS)存在挑戰，同時預計EPS將受其他因素的負面影響。然而，管理層並不預計會出現重大下滑，只是在實現增長方面存在困難。考慮到有機銷售的強勁表現以及基於收益的合理估值，預計該公司將吸引投資者的關注。
以下爲今日8位分析師對$億滋 (MDLZ.US)$的最新投資評級及目標價：
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
